Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,760 | 1,131 | 1,939 | 1,857 | 1,664 |
| TOTAL | $1,760 | $1,131 | $1,939 | $1,857 | $1,664 |
| Non-Current Assets | |||||
| Investments And Advances | 7,630 | 7,643 | 7,080 | 7,761 | 6,072 |
| Other Non-Current Assets | 16,520 | 14,574 | 14,704 | 13,846 | 13,889 |
| TOTAL | $24,150 | $22,217 | $21,784 | $21,607 | $19,961 |
| Total Assets | $25,910 | $23,348 | $23,723 | $23,464 | $21,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 11 | 27 |
| Accounts payable and accrued liabilities | 0 | 12,281 | 3,160 | 13,241 | 12,407 |
| Accrued Expenses | N/A | 0 | 9,992 | 0 | 0 |
| Other current liabilities | 14,050 | 13,360 | 14,855 | 13,716 | 14,663 |
| TOTAL | $14,050 | $25,641 | $28,007 | $26,968 | $27,097 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 720 | 4,722 | 5,099 | 5,210 | 5,526 |
| TOTAL | $720 | $7,265 | $7,540 | $7,813 | $7,611 |
| Total Liabilities | $14,770 | $32,906 | $35,547 | $34,781 | $34,708 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 14 | 13 | 13 | 13 |
| Other shareholders' equity | 330 | -63 | 461 | -230 | 36 |
| TOTAL | $66,060 | $65,261 | $65,482 | $66,385 | $67,099 |
| Total Liabilities And Equity | $80,830 | $98,167 | $101,029 | $101,166 | $101,807 |